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Abstract: The change of blood picture at the 3rd day of Diethylcarbamazine (DEC)
administration was studied in thirty-two Guatemalan patients with onchocerciasis. They
were administered DEC tablets dialy seven consecutive days at the dosage of 5mg/kg
body weigth.
The increase of total white blood cell counts was statistically significant between
before and the day 3 of administration. The increase of total white blood cell counts
was due to that of nuetrophil counts. The changes of eosinophil and lymphocyte counts
were not statistically significant. The relation between the change of blood picture and
the number of microfilariae in the skin snip was not seen.
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Diethylcarbamazine (DEC) is widely used in chemotherapy of human filariasis,
being particularly effective against microfilariae. Administration of DEC causes severe
local and systemic reactions in the patients with onchocerciasis, which are scarecely en-
countered during the treatment of malayan and bancroftian filariasis. This type of re-
action observed in onchocerciasis (Mazzotti, 1948) has been referred as "Mazzotti test",
and has been extestively used in some areas as a diagnostic measure.
The clinical and histological feature of inflammatory reaction shown in DEC ad-
ministration has been intensively studied (Hawking, 1952 ; Fulgsang and Anderson, 1974 ;
Fazen et al., 1976; Bryceson et al., 1977; Tada et al., 1981). However, little is known
about haematology during DEC treatment (Money, 1980 ; Guerra-Caceres et al. , 1980).
In Amatitlan General Hospital, Guatemala, we treated 32 patients with onchocer-
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ciasis by DEC. Before treatment, two skin snips were taken from shoulder and iliac
regions of each patient using a corneo-scleral punch. The patients were then given
DEC (Hetrazan) orally at the dosage of 5 mg/kg body weigth for 7 consecutive days.
Before and 3 days after the initiation of treatment, haematological examination was
carried out. Total number of white blood cell (WBC) per cubic millimeter of blood
was counted by conventional method and differential cell count was assessed under
Giemsa staining. The blood examination was made between 9 :00 and 10 :00 am.
The result was summarized in Table 1. The patients were classified into following
three groups according to microfilariae density (MFD), expressed as a total count of
microfilariae emerged from two snips; low (less than 10 mf), moderate (10 to 49 mf),
and high density (50 and more mf) groups.
On day 3 of treatment, the total WBC count was found to be raised in all of 6
patients with low MFD, in 12 of 15 of those with moderate MFD, and in 10 of ll of
those with high MFD. The rate of increase varied from 2 to 183 per cent of the initial
count. Although in 3 out of 32 patients, a reduction of total WBC count was observed,
the decrease was slight, 2 to 18 per cent of the initial count. Using Student's t test,
difference in total WBC count between before and 3 days after the initiation of trea-
tment was significant in low MFD group (p<0.02), in moderate MFD group (p<0.01)
and high MFD group (P<^0.01). However, there was no clear difference in the incre-
ase of total WBC count among the three groups.
Differential count study showed that neutrophils increased in 27 of 32 cases with
the range from 3 to 268 % of initial count. In two thirds of these cases, the increase
in neutrophil count exceeded more than 30 % of initial count. The difference in neu-
trophil count before and 3 days after the initiation of treatment with DEC was statisti-
cally significant in all groups. The change in eosinophil count was quite variable.
Of 32 cases, 14 showed increase in count exceeding 40 % of initial count, 8 ranged
between +40 % and -40%, and 10 showed reduction under 40 % of the initial count.
In lymphocyte count, an increase was more frequent (21 cases) than a reduction (ll
cases). Of 28 cases with the increase of total WBC, the increase of neutrophil,
eosinophil and lymphocyte was observed in 25, 17, and 19 cases respectively. The





C ount before treatment^ Count on day 3 of treatment




6 6651±1538 3993+903 1245+591 1347±579
15 6613+1956 3591+1493 1504+859 1385±756
ll 7439+3259 4896+2639 1150+1081 1330±503
9903+1415 6463±836 1308±978 1907+1066
8061±2161 4691±1508 1549+844 1549±667
1105913264 6605+2745 2057+2243 2179+1220
^Number of cells/mm3
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increase of total WBC is more likely related with the increase of the neutrophil･
It is generally considered that inflammatory reaction caused by DEC administration
is the result of speedy killing of microfilariae･ The histological studies of reaction
showed that neutrophils, eosinophils and lymphocytes appeared in close proximity to
damaged microfilariae (Hawking, 1952; Gibson et al. , 1976°　　Althouth we did not
examine blood picture of patients on concecutive days following administration of DEC,
our study showed that the marked increase of total WI∋C was observed on day 3 of
treatment and it was mainly due to the increase of neutrophils. This confirms DEC-
induced inflammatory reaction in host. Henson et al. (1979) emphasized that neutrophils
were also seen in Onchocerca volvulus reaction, and described a suspected involvment of
neutrophils in killing microfilariae. Neutrophils probably play an important role in
exacerbation caused by DEC.
The particular role of eosinophils have been discussed in inflammatory reaction
(Bryceron, 1976; Henson et al･, 1979; Guerra-Caceres et al., 1980)･　Regarding the
changes of eosinophils during the treatment of onchocerciasis, Money (1960) reported
that the change was 43 % (0-99 %) depression of basal count and that the depression
exceeded 40 % of initial count in 9 of 12 cases.
Guerra-Caceres et al. (1980) also observed that eosinophil counts fell to well below the
initial level at 12 hours after DEC treatment and they returned to the previous level at
24 hours. Our present study showed 1 to 84 % decrease of the initial count in 14
cases among the subjects. The statistical analysis indicated that the eosinophil reducing
effect of DEC was not significant in our cases. As our observation was made on day
3 of treatment, the discrepancy will be seen.
Further haematological studies, including the serial measurment of differential
cell count, will be helpful to understand the generation of adverse reaction caused by
administration of DEC to patients with onchocerciasis.
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オンコセルカ症に於るDietnylcarbamazineの末梢血液像に与える影響
坂本信, G. Z. Flores
オンコセル症の治療目的でDiethylcarbamazine(DEC)を経口投与した時の末梢血液像の変化
を32名の患者について観察した.DECの投与により総白血球は有意に上昇し,その原因は血球
分画における好中球の増加によるものと考えられる.好酸球,リンパ球の変動に有意差はみられ
なかった.仔虫密度のDEC投与時における末梢血液像に与える影響はあまりみられなかった.
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